首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >External quality control assessment in PCR diagnostics of dengue virus infections.
【24h】

External quality control assessment in PCR diagnostics of dengue virus infections.

机译:PCR诊断登革热病毒感染的外部质量控制评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Increased travelling to countries endemic for dengue fever (DF) demands efficient laboratory diagnostics. Nucleic acid amplification techniques (NAT) are now frequently used for rapid diagnosis of imported viral diseases. Different PCR systems are available. Objectives: In order to assess the quality of molecular diagnostics of dengue virus infections, an external quality assurance (EQA) in PCR diagnostics was conducted. Study design: A panel of 10 human plasma samples was prepared and spiked with dengue virus types DEN-1 to DEN-4. In addition, a 10-fold dilution series (1:10-1:10(4) ) of DEN-3 virus was included. The panel was pre-tested by nested RT-PCR, in-house real-time PCR, and a commercial real-time PCR kit. The samples were inactivated by gamma irradiation and shipped in freeze dried state. Thirteen laboratories, within the European network for the diagnostics of imported viral diseases (ENIVD) took part using either single-round, nested, or real-time RT-PCR methods. Two laboratories used two methods in parallel, summarising up to 15 comparable results. Results: 33-100% correct results were achieved. All laboratories detected DEN-2 correctly, followed by DEN-1 (14 positive results of 15), DEN-3 (12/15) and DEN-4 (11/15). Testing of the serial dilution revealed low sensitivity in many labs, with results ranging from 33 to 80% of correctly tested samples. Conclusion: The EQA gives a feedback of the quality of the RT-PCR system used by each respective laboratory. The different test systems and amplification conditions demonstrate the importance of external quality control measures.
机译:背景:前往登革热地方病(DF)的国家/地区的旅行越来越多,需要进行高效的实验室诊断。核酸扩增技术(NAT)现在经常用于快速诊断进口病毒性疾病。可以使用不同的PCR系统。目的:为了评估登革热病毒感染分子诊断的质量,在PCR诊断中进行了外部质量保证(EQA)。研究设计:制备一组10个人血浆样品,并掺入DEN-1至DEN-4型登革热病毒。此外,还包括DEN-3病毒的10倍稀释系列(1:10-1:10(4))。通过嵌套RT-PCR,内部实时PCR和商业实时PCR试剂盒对面板进行了预测试。样品通过伽马射线辐照灭活,并以冷冻干燥状态运输。在欧洲网络中,有13个实验室使用单轮,嵌套或实时RT-PCR方法来诊断进口病毒性疾病(ENIVD)。两个实验室并行使用两种方法,总结了多达15个可比较的结果。结果:获得了33-100%的正确结果。所有实验室均正确检测到DEN-2,然后依次检测到DEN-1(14个阳性结果,为15),DEN-3(12/15)和DEN-4(11/15)。对系列稀释液的测试表明,在许多实验室中灵敏度较低,结果占正确测试样品的33%至80%。结论:EQA反馈了每个实验室使用的RT-PCR系统的质量。不同的测试系统和放大条件证明了外部质量控制措施的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号